Ayden Scheim is a Canadian Institutes of Health Research Postdoctoral Fellow in the Division of Infectious Diseases and Global Public Health at the University of California, San Diego and Associate Scientist in the Centre on Drug Policy Evaluation at St. Michael’s Hospital in Toronto. He holds a Ph.D. (2017) in Epidemiology and Biostatistics from Western University in London, Canada, where he was a Pierre Elliott Trudeau Foundation Scholar and Vanier Canada Graduate Scholar. Dr. Scheim investigates the impacts of social, policy, and healthcare environments on the health of stigmatized populations. In particular, his research program involves community-engaged research with transgender populations and people who use drugs, both domestically and globally.
Dr. Scheim’s doctoral research examined the impacts of discrimination on health behaviours among transgender people in Ontario, Canada, and developed a new instrument for measuring discrimination intersectionally in population health research. He is currently leading the scientific evaluation of supervised consumption services integrated within community health agencies in Toronto and is Co-Principal Investigator for Trans PULSE Canada, a national survey of transgender health.
Dr. Scheim also provides research, evaluation, and training services as a consultant. All of his work is informed by over a decade of front-line experience providing trans health, HIV prevention, and harm reduction services.